APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biologic Therapeutic Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biologic Therapeutic Drug Market Outlook and Growth Opportunities 2026

31 December 2025195 pages

Choose your research edition.

Industry ResearchBiologic Therapeutic Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologic Therapeutic Drug Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biologic Therapeutic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologic Therapeutic Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologic Therapeutic Drug Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Biologic Therapeutic Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biologic Therapeutic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biologic Therapeutic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biologic Therapeutic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biologic Therapeutic Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biologic Therapeutic Drug market include Merck and Co. Inc., Pfizer Inc., AstraZeneca, Smith Medical, Retractable Technologies, Inc., Novartis Global, H. Lundbeck A/S, GlaxoSmithKline Plc. and Concord Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Biologic Therapeutic Drug market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biologic Therapeutic Drug and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biologic Therapeutic Drug revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biologic Therapeutic Drug market.

Biologic Therapeutic Drug Segment by Company

Merck and Co. Inc.

Pfizer Inc.

AstraZeneca

Smith Medical

Retractable Technologies, Inc.

Novartis Global

H. Lundbeck A/S

GlaxoSmithKline Plc.

Concord Biotech

Aurobindo Pharma Ltd.

Biologic Therapeutic Drug Segment by Type

Monoclonal Antibodies

Vaccines

Therapeutic Proteins

Biologic Therapeutic Drug Segment by Application

Clinical Medicine

Laboratory

Others

Biologic Therapeutic Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Biologic Therapeutic Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Biologic Therapeutic Drug key companies, revenue, market share, and recent developments.

3. To split the Biologic Therapeutic Drug breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Biologic Therapeutic Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biologic Therapeutic Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Biologic Therapeutic Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic Therapeutic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologic Therapeutic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic Therapeutic Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biologic Therapeutic Drug industry.

Chapter 3: Detailed analysis of Biologic Therapeutic Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Biologic Therapeutic Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Biologic Therapeutic Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biologic Therapeutic Drug Industry Trends Table 2. Biologic Therapeutic Drug Industry Drivers Table 3. Biologic Therapeutic Drug Industry Opportunities and Challenges Table 4. Biologic Therapeutic Drug Industry Restraints Table 5. Global Biologic Therapeutic Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biologic Therapeutic Drug Revenue Share by Company (2021-2026) Table 7. Global Biologic Therapeutic Drug Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Biologic Therapeutic Drug Key Company Manufacturing Base & Headquarters Table 9. Global Biologic Therapeutic Drug Company, Product Type & Application Table 10. Global Biologic Therapeutic Drug Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Biologic Therapeutic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Monoclonal Antibodies Table 15. Significant Companies of Vaccines Table 16. Significant Companies of Therapeutic Proteins Table 17. Global Biologic Therapeutic Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Biologic Therapeutic Drug Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Biologic Therapeutic Drug Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Biologic Therapeutic Drug Sales Value Share by Type (2021-2026) Table 21. Global Biologic Therapeutic Drug Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Clinical Medicine Table 23. Significant Companies of Laboratory Table 24. Significant Companies of Others Table 25. Global Biologic Therapeutic Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Biologic Therapeutic Drug Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Biologic Therapeutic Drug Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Biologic Therapeutic Drug Sales Value Share by Application (2021-2026) Table 29. Global Biologic Therapeutic Drug Sales Value Share by Application (2027-2032) Table 30. Global Biologic Therapeutic Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Biologic Therapeutic Drug Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Biologic Therapeutic Drug Sales Value Share by Region (2021-2026) Table 33. Global Biologic Therapeutic Drug Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Biologic Therapeutic Drug Sales Value Share by Region (2027-2032) Table 35. Global Biologic Therapeutic Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Biologic Therapeutic Drug Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Biologic Therapeutic Drug Sales Value Market Share by Country (2021-2026) Table 38. Global Biologic Therapeutic Drug Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Biologic Therapeutic Drug Sales Value Market Share by Country (2027-2032) Table 40. Merck and Co. Inc. Company Information Table 41. Merck and Co. Inc. Business Overview Table 42. Merck and Co. Inc. Biologic Therapeutic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Merck and Co. Inc. Biologic Therapeutic Drug Product Portfolio Table 44. Merck and Co. Inc. Recent Development Table 45. Pfizer Inc. Company Information Table 46. Pfizer Inc. Business Overview Table 47. Pfizer Inc. Biologic Therapeutic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Pfizer Inc. Biologic Therapeutic Drug Product Portfolio Table 49. Pfizer Inc. Recent Development Table 50. AstraZeneca Company Information Table 51. AstraZeneca Business Overview Table 52. AstraZeneca Biologic Therapeutic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. AstraZeneca Biologic Therapeutic Drug Product Portfolio Table 54. AstraZeneca Recent Development Table 55. Smith Medical Company Information Table 56. Smith Medical Business Overview Table 57. Smith Medical Biologic Therapeutic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Smith Medical Biologic Therapeutic Drug Product Portfolio Table 59. Smith Medical Recent Development Table 60. Retractable Technologies, Inc. Company Information Table 61. Retractable Technologies, Inc. Business Overview Table 62. Retractable Technologies, Inc. Biologic Therapeutic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Retractable Technologies, Inc. Biologic Therapeutic Drug Product Portfolio Table 64. Retractable Technologies, Inc. Recent Development Table 65. Novartis Global Company Information Table 66. Novartis Global Business Overview Table 67. Novartis Global Biologic Therapeutic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Novartis Global Biologic Therapeutic Drug Product Portfolio Table 69. Novartis Global Recent Development Table 70. H. Lundbeck A/S Company Information Table 71. H. Lundbeck A/S Business Overview Table 72. H. Lundbeck A/S Biologic Therapeutic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. H. Lundbeck A/S Biologic Therapeutic Drug Product Portfolio Table 74. H. Lundbeck A/S Recent Development Table 75. GlaxoSmithKline Plc. Company Information Table 76. GlaxoSmithKline Plc. Business Overview Table 77. GlaxoSmithKline Plc. Biologic Therapeutic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. GlaxoSmithKline Plc. Biologic Therapeutic Drug Product Portfolio Table 79. GlaxoSmithKline Plc. Recent Development Table 80. Concord Biotech Company Information Table 81. Concord Biotech Business Overview Table 82. Concord Biotech Biologic Therapeutic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Concord Biotech Biologic Therapeutic Drug Product Portfolio Table 84. Concord Biotech Recent Development Table 85. Aurobindo Pharma Ltd. Company Information Table 86. Aurobindo Pharma Ltd. Business Overview Table 87. Aurobindo Pharma Ltd. Biologic Therapeutic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Aurobindo Pharma Ltd. Biologic Therapeutic Drug Product Portfolio Table 89. Aurobindo Pharma Ltd. Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Biologic Therapeutic Drug Product Image Figure 2. Global Biologic Therapeutic Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Biologic Therapeutic Drug Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Monoclonal Antibodies Image Figure 8. Vaccines Image Figure 9. Therapeutic Proteins Image Figure 10. Global Biologic Therapeutic Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Biologic Therapeutic Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Biologic Therapeutic Drug Sales Value Share by Type (2021-2032) Figure 13. Clinical Medicine Image Figure 14. Laboratory Image Figure 15. Others Image Figure 16. Global Biologic Therapeutic Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Biologic Therapeutic Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Biologic Therapeutic Drug Sales Value Share by Application (2021-2032) Figure 19. Global Biologic Therapeutic Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Biologic Therapeutic Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Biologic Therapeutic Drug Sales Value (2021-2032) & (US$ Million) Figure 22. North America Biologic Therapeutic Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Biologic Therapeutic Drug Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Biologic Therapeutic Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Biologic Therapeutic Drug Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Biologic Therapeutic Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Biologic Therapeutic Drug Sales Value (2021-2032) & (US$ Million) Figure 28. South America Biologic Therapeutic Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Biologic Therapeutic Drug Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Biologic Therapeutic Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibodies
  • Vaccines
  • Therapeutic Proteins
Applications
  • Clinical Medicine
  • Laboratory
  • Others
Companies covered
  • Merck and Co. Inc.
  • Pfizer Inc.
  • AstraZeneca
  • Smith Medical
  • Retractable Technologies, Inc.
  • Novartis Global
  • H. Lundbeck A/S
  • GlaxoSmithKline Plc.
  • Concord Biotech
  • Aurobindo Pharma Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biologic Therapeutic Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biologic Therapeutic Drug Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biologic Therapeutic Drug Market Dynamics
  1. 2.1 Biologic Therapeutic Drug Industry Trends
  2. 2.2 Biologic Therapeutic Drug Industry Drivers
  3. 2.3 Biologic Therapeutic Drug Industry Opportunities and Challenges
  4. 2.4 Biologic Therapeutic Drug Industry Restraints
3 Biologic Therapeutic Drug Market by Company
  1. 3.1 Global Biologic Therapeutic Drug Company Revenue Ranking in 2025
  2. 3.2 Global Biologic Therapeutic Drug Revenue by Company (2021-2026)
  3. 3.3 Global Biologic Therapeutic Drug Company Ranking (2024-2026)
  4. 3.4 Global Biologic Therapeutic Drug Company Manufacturing Base and Headquarters
  5. 3.5 Global Biologic Therapeutic Drug Company Product Type and Application
  6. 3.6 Global Biologic Therapeutic Drug Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biologic Therapeutic Drug Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biologic Therapeutic Drug Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biologic Therapeutic Drug Market by Type
  1. 4.1 Biologic Therapeutic Drug Type Introduction
  2. 4.1.1 Monoclonal Antibodies
  3. 4.1.2 Vaccines
  4. 4.1.3 Therapeutic Proteins
  5. 4.2 Global Biologic Therapeutic Drug Sales Value by Type
  6. 4.2.1 Global Biologic Therapeutic Drug Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Biologic Therapeutic Drug Sales Value by Type (2021-2032)
  8. 4.2.3 Global Biologic Therapeutic Drug Sales Value Share by Type (2021-2032)
5 Biologic Therapeutic Drug Market by Application
  1. 5.1 Biologic Therapeutic Drug Application Introduction
  2. 5.1.1 Clinical Medicine
  3. 5.1.2 Laboratory
  4. 5.1.3 Others
  5. 5.2 Global Biologic Therapeutic Drug Sales Value by Application
  6. 5.2.1 Global Biologic Therapeutic Drug Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biologic Therapeutic Drug Sales Value by Application (2021-2032)
  8. 5.2.3 Global Biologic Therapeutic Drug Sales Value Share by Application (2021-2032)
6 Biologic Therapeutic Drug Regional Value Analysis
  1. 6.1 Global Biologic Therapeutic Drug Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biologic Therapeutic Drug Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biologic Therapeutic Drug Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biologic Therapeutic Drug Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biologic Therapeutic Drug Sales Value (2021-2032)
  7. 6.3.2 North America Biologic Therapeutic Drug Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biologic Therapeutic Drug Sales Value (2021-2032)
  10. 6.4.2 Europe Biologic Therapeutic Drug Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biologic Therapeutic Drug Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biologic Therapeutic Drug Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biologic Therapeutic Drug Sales Value (2021-2032)
  16. 6.6.2 South America Biologic Therapeutic Drug Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biologic Therapeutic Drug Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biologic Therapeutic Drug Sales Value Share by Country, 2025 VS 2032
7 Biologic Therapeutic Drug Country-level Value Analysis
  1. 7.1 Global Biologic Therapeutic Drug Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biologic Therapeutic Drug Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biologic Therapeutic Drug Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biologic Therapeutic Drug Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biologic Therapeutic Drug Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biologic Therapeutic Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biologic Therapeutic Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck and Co. Inc.
  2. 8.1.1 Merck and Co. Inc. Company Information
  3. 8.1.2 Merck and Co. Inc. Business Overview
  4. 8.1.3 Merck and Co. Inc. Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck and Co. Inc. Biologic Therapeutic Drug Product Portfolio
  6. 8.1.5 Merck and Co. Inc. Recent Developments
  7. 8.2 Pfizer Inc.
  8. 8.2.1 Pfizer Inc. Company Information
  9. 8.2.2 Pfizer Inc. Business Overview
  10. 8.2.3 Pfizer Inc. Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Inc. Biologic Therapeutic Drug Product Portfolio
  12. 8.2.5 Pfizer Inc. Recent Developments
  13. 8.3 AstraZeneca
  14. 8.3.1 AstraZeneca Company Information
  15. 8.3.2 AstraZeneca Business Overview
  16. 8.3.3 AstraZeneca Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AstraZeneca Biologic Therapeutic Drug Product Portfolio
  18. 8.3.5 AstraZeneca Recent Developments
  19. 8.4 Smith Medical
  20. 8.4.1 Smith Medical Company Information
  21. 8.4.2 Smith Medical Business Overview
  22. 8.4.3 Smith Medical Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Smith Medical Biologic Therapeutic Drug Product Portfolio
  24. 8.4.5 Smith Medical Recent Developments
  25. 8.5 Retractable Technologies, Inc.
  26. 8.5.1 Retractable Technologies, Inc. Company Information
  27. 8.5.2 Retractable Technologies, Inc. Business Overview
  28. 8.5.3 Retractable Technologies, Inc. Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Retractable Technologies, Inc. Biologic Therapeutic Drug Product Portfolio
  30. 8.5.5 Retractable Technologies, Inc. Recent Developments
  31. 8.6 Novartis Global
  32. 8.6.1 Novartis Global Company Information
  33. 8.6.2 Novartis Global Business Overview
  34. 8.6.3 Novartis Global Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novartis Global Biologic Therapeutic Drug Product Portfolio
  36. 8.6.5 Novartis Global Recent Developments
  37. 8.7 H. Lundbeck A/S
  38. 8.7.1 H. Lundbeck A/S Company Information
  39. 8.7.2 H. Lundbeck A/S Business Overview
  40. 8.7.3 H. Lundbeck A/S Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  41. 8.7.4 H. Lundbeck A/S Biologic Therapeutic Drug Product Portfolio
  42. 8.7.5 H. Lundbeck A/S Recent Developments
  43. 8.8 GlaxoSmithKline Plc.
  44. 8.8.1 GlaxoSmithKline Plc. Company Information
  45. 8.8.2 GlaxoSmithKline Plc. Business Overview
  46. 8.8.3 GlaxoSmithKline Plc. Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GlaxoSmithKline Plc. Biologic Therapeutic Drug Product Portfolio
  48. 8.8.5 GlaxoSmithKline Plc. Recent Developments
  49. 8.9 Concord Biotech
  50. 8.9.1 Concord Biotech Company Information
  51. 8.9.2 Concord Biotech Business Overview
  52. 8.9.3 Concord Biotech Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Concord Biotech Biologic Therapeutic Drug Product Portfolio
  54. 8.9.5 Concord Biotech Recent Developments
  55. 8.10 Aurobindo Pharma Ltd.
  56. 8.10.1 Aurobindo Pharma Ltd. Company Information
  57. 8.10.2 Aurobindo Pharma Ltd. Business Overview
  58. 8.10.3 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Product Portfolio
  60. 8.10.5 Aurobindo Pharma Ltd. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst